Some people are microdosing certain weight loss drugs in an attempt to reap some of the drugs' benefits with fewer of their side effects. But doctors specializing in weight loss say that ...

Injectable GLP-1 agonists help people struggling to lose weight. Patients are finding the drug also helps reduce recurring ...

Metsera's MET-097i shows 11.3% weight loss in Phase 2a trial, beating Wegovy and Zepbound at 3 months, with potential for ...

Metsera has linked its GLP-1 drug candidate to weight loss of up to 11.3% after 12 weeks, encouraging the biotech to use some ...

Ozempic is approved for type 2 diabetes, while its counterpart, Wegovy, is approved for treating obesity ... on the starting doses or don’t go all the way up in the escalation titration dosing of the ...

Lilly’s offering is expected to surpass Novo’s Wegovy in the space, and, according to a report this week from GlobalData, it could happen much sooner than later. The analysts pointed to ...

I then noticed myself drifting backward and craving sweets again. My doctor increased my dose to 1.7 mg of Wegovy instead of 2 mg of Ozempic. I find myself continuing to crave sweets and have ...

Start your Independent Premium subscription today. I’ve been on Wegovy – a weight loss medication I inject once a week – for three months. I have lost 10.9kg (1st 10lb). Like me, thousands ...

With the Christmas posts, Musk has now shared publicly that he has tried Mounjaro, Ozempic and Wegovy, another treatment from Novo Nordisk. You may not be a billionaire like Elon Musk, but you can ...

Eli Lilly & Co.'s Zepbound obesity drug. (Shelby Knowles/Bloomberg) This time last year, people were still bickering about whether Novo Nordisk’s Wegovy and Eli Lilly & Co.’s Zepbound ...

Starting in the new year, Independence Blue Cross, the region’s largest health insurer, will no longer cover anti-obesity drugs like Ozempic and Wegovy when they’re prescribed solely for weight loss.